1 option
Nanofluidic Isolation and Quantification of Specific Extracellular Vesicles and Machine Learning Analysis to Aid Clinical Decision-Making / Hanfei Shen.
- Format:
- Book
- Thesis/Dissertation
- Author/Creator:
- Shen, Hanfei, author.
- Language:
- English
- Subjects (All):
- Bioengineering.
- Biomedical engineering.
- Nanotechnology.
- Bioinformatics.
- Bioengineering--Penn dissertations.
- Penn dissertations--Bioengineering.
- Local Subjects:
- Bioengineering.
- Biomedical engineering.
- Nanotechnology.
- Bioinformatics.
- Bioengineering--Penn dissertations.
- Penn dissertations--Bioengineering.
- Physical Description:
- 1 online resource (264 pages)
- Contained In:
- Dissertations Abstracts International 85-12B.
- Place of Publication:
- [Philadelphia, Pennsylvania] : University of Pennsylvania, 2022.
- Ann Arbor : ProQuest Dissertations & Theses, 2024
- Language Note:
- English
- Summary:
- Extracellular vesicles (EVs) hold immense promise as reservoirs of critical biomarkers for diagnosing and prognosing various diseases. However, leveraging their potential in clinical settings faces significant obstacles, including precise detection, quantification, and isolation of specific EV subgroups, as well as complex analysis of liquid biopsy (LB) datasets derived from EV cargoes. In response to these challenges, particularly in the realms of oncology and neurology, our research employs a comprehensive strategy.Developing on existing high throughput nanofluidic EV isolation platform, we have significantly improved the specificity when isolating EV subpopulations using surface markers. We focused on the analysis of EV-miRNAs and, when combined with the evaluation of circulating protein biomarkers, generated predictive insights relevant to a range of clinical questions. Specifically, we isolated neuron-derived EVs to diagnose and prognose neurological outcomes post-cardiac-arrest brain injury, and EVs from non-small-cell lung cancer cells to predict immunotherapy responses. In quantifying EV subpopulations, our Droplet-based Extracellular Vesicle Analysis (DEVA) achieved limits of detection (LOD) and quantification (LOQ) that are more than 100 times lower than those achieved by the gold standard conventional ELISA. When applied to the quantification of EVs expressing surface Programmed Death-Ligand 1 (PD-L1), in both cell culture samples and human plasma, DEVA maintained the low LOD and LOQ and agreed with gold standard method, offering potential in immunotherapy outcome prediction and melanoma prognosis.To streamline LB dataset analysis, we developed a web-based, automated machine learning tool validated across 11 datasets. Its performance rivals or exceeds custom-designed algorithms, with capacity for improvement through historical data assimilation. A differential privacy algorithm which manages information feedback to users, was integrated to counter overfitting.These advancements represent a concerted effort to explore EVs' diagnostic and prognostic potential in clinical scenarios, with a focus on patient outcomes in cancer and brain injury. Our work is dedicated to cultivating more accurate and targeted biomarker analyses, addressing critical challenges in EV research for enhanced clinical utility.
- Notes:
- Source: Dissertations Abstracts International, Volume: 85-12, Section: B.
- Advisors: Issadore, David A.; Tsourkas, Andrew; Committee members: Meaney, David F.; Kim, Junhyong; Radhakrishnan, Ravi.
- Department: Bioengineering.
- Ph.D. University of Pennsylvania 2024.
- Local Notes:
- School code: 0175
- ISBN:
- 9798382836232
- Access Restriction:
- Restricted for use by site license.
- This item is not available from ProQuest Dissertations & Theses.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.